Nerandomilast: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Nerandomilast. Educational only — not medical advice.

Labeled uses

JASCAYD is a phosphodiesterase 4 (PDE4) inhibitor indicated for: The treatment of idiopathic pulmonary fibrosis in adult patients. (1.1 ) The treatment of progressive pulmonary fibrosis in adult patients. (1.2 )

Source: FDA labeling via NIH DailyMed (set fa1b14c6…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.